Literature DB >> 16532672

Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran.

M R Zali1, K Mohammad, A A Noorbala, B Noorimayer, S Shahraz, S Sahraz.   

Abstract

Universal vaccination of all neonates against hepatitis B virus has been implemented in the Islamic Republic of Iran since 1993. To evaluate the efficacy of the programme, 2 large seroepidemiologic surveys were conducted before and after mass vaccination on a representative sample of 1/1000 of the population. The overall seropositivity rate showed no significant decline between 1991 and 1999 but in the age group 2-14 years the rates reduced significantly (1.3% versus 0.8%, P < 0.05). Interestingly, we observed a significantly higher decline in hepatitis B virus carrier rate in rural (1.5% versus 0.6%) than urban areas (1.1% versus 0.9%). Universal vaccination significantly decreased the carrier rate among young children in this country.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16532672

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  27 in total

1.  Active-passive Immunization Effectiveness Against Hepatitis B Virus in Children Born to HBsAg Positive Mothers in Amol, North of Iran.

Authors:  Yousef Yahyapour; Mohammad Karimi; Hamid-Reza Molaei; Esmaeil Khoddami; Mahmoud Mahmoudi
Journal:  Oman Med J       Date:  2011-11

2.  Viral hepatitis induces hepatocellular cancer: what can we learn from epidemiology comparing iran and worldwide findings?

Authors:  Elisabeth Smolle; Evelyn Zöhrer; Kira Bettermann; Johannes Haybaeck
Journal:  Hepat Mon       Date:  2012-10-30       Impact factor: 0.660

3.  Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in iran and worldwide.

Authors:  Ahmed Zidan; Hubert Scheuerlein; Silke Schüle; Utz Settmacher; Falk Rauchfuss
Journal:  Hepat Mon       Date:  2012-10-24       Impact factor: 0.660

4.  Seroprevalence study of hepatitis C and Hepatitis B virus among hospitalized intravenous drug users in Ahvaz, Iran (2002-2006).

Authors:  Seyed Mohammad Alavi; Fatemeh Behdad
Journal:  Hepat Mon       Date:  2010-06-01       Impact factor: 0.660

5.  Prevalence of chronic hepatitis B infection in Iran: a review article.

Authors:  Jalal Poorolajal; Reza Majdzadeh
Journal:  J Res Med Sci       Date:  2009-07       Impact factor: 1.852

6.  The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran.

Authors:  Farhad Fathimoghaddam; Mohammad Reza Hedayati-Moghaddam; Hamid Reza Bidkhori; Sanaz Ahmadi; Hamid Reza Sima
Journal:  Hepat Mon       Date:  2011-05       Impact factor: 0.660

7.  Should a booster dose be administered in children after mass immunization for hepatitis B?

Authors:  Selma Tosun; Serol Deveci; Yunus Kaplan; Erhun Kasirga
Journal:  Hepat Mon       Date:  2011-06       Impact factor: 0.660

Review 8.  Estimation of Cancer Burden Attributable to Infection in Asia.

Authors:  He Huang; Xiao-Feng Hu; Fang-Hui Zhao; Suzanne M Garland; Neerja Bhatla; You-Lin Qiao
Journal:  J Epidemiol       Date:  2015-09-19       Impact factor: 3.211

9.  Intra-familial Transmission of Hepatitis B virus Infection in Zahedan.

Authors:  Hossein Hatami; Masoud Salehi; Esmail Sanei; Soheila Khosravi; Seyed Moayed Alavian
Journal:  Iran Red Crescent Med J       Date:  2013-01-05       Impact factor: 0.611

10.  Seroprevalence of hepatitis B surface antigen and anti hepatitis C antibody in zahedan city, iran: a population-based study.

Authors:  Alireza Ansari-Moghaddam; Mohammad Reza Ostovaneh; Batool Sharifi Mood; Esmail Sanei-Moghaddam; Amirhossein Modabbernia; Hossein Poustchi
Journal:  Hepat Mon       Date:  2012-09-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.